PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Aug-2021 Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility Quotient Sciences
26-Aug-2021 Achilles Therapeutics Announces Grant of US and European Patents Achilles Therapeutics
26-Aug-2021 Spinal Muscular Atrophy Treatment Market Witnesses Static Increase in Patent Filings Since 2015: Sagacious IP Sagacious IP
26-Aug-2021 Asklepios Kliniken: Coronavirus pandemic still having an impact in H1 2021 Asklepios Kliniken
26-Aug-2021 Evolva accelerated revenue growth to 60% and expects gross profit to be positive from Q4, 2021 Evolva Holding SA
26-Aug-2021 Philippe Deecke appointed as Chief Financial Officer of Lonza Group Lonza Group AG
26-Aug-2021 Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention of CMV infection of the unborn baby Biotest AG
25-Aug-2021 Achilles Therapeutics Announces Grant of US and European Patents Achilles Therapeutics
25-Aug-2021 NovaBiotics Highlights Advantages of Novel Immune-Based Approach to Combatting Fungal and Bacterial Infectious Diseases at Peptide Therapeutics Forum 2021 NovaBiotics
25-Aug-2021 M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued Corona burdens M1 Kliniken AG
25-Aug-2021 Aptamer Group and Bio-Works Technologies partner to enable improved solutions for gene therapy manufacturing Aptamer Group
25-Aug-2021 Medios AG: Accelerated roll-out of the digital platform mediosconnect Medios AG
25-Aug-2021 Douglas significantly boosts sales in third quarter Douglas GmbH
24-Aug-2021 Health Canada Grants Marketing Authorization for Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma MorphoSys AG
24-Aug-2021 Orgenesis announces collaboration agreement with Savicell to license and deploy its ImmunoBiopsy(TM) platform Orgenesis
24-Aug-2021 BioGenes and FyoniBio Combine Their Scientific Expertise and Cooperate on Pharmacokinetic and Immunogenicity Analyses BioGenes and FyoniBio
24-Aug-2021 HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD) HMNC Brain Health
24-Aug-2021 Epigenomics AG: Securities prospectus for the issuance of a mandatory convertible bond in the amount of up to EUR 16.5 million approved by BaFin Epigenomics AG
24-Aug-2021 BioGenes and FyoniBio Combine Their Scientific Expertise and Cooperate on Pharmacokinetic and Immunogenicity Analyses B3C newswire
24-Aug-2021 Health app Well heralds the future of healthcare Zur Rose Group AG